Sleep to lower elevated blood pressure: Study protocol for a randomized controlled trial

Trials

Volumn 15, Issue 1, 2014, Pages

  McGrath, Emer R ^a,b   Espie, Colin A ^c   Murphy, Andrew W ^c   Newell, John ^a   Power, Alice ^a   Madden, Sarah ^a   Byrne, Molly ^a   O'Donnell, Martin J ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiovascular disease; Hypertension; Sleep

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COGNITIVE THERAPY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSOMNIA SEVERITY INDEX SCORE; INTENTION TO TREAT ANALYSIS; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NEUROLOGIC EXAMINATION; ONLINE SYSTEM; PATIENT COMPLIANCE; PATIENT EDUCATION; PERSONAL HYGIENE; PHASE 2 CLINICAL TRIAL; PITTSBURGH SLEEP QUALITY INDEX; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP CONDITION INDICATOR SCORE; SLEEP PATTERN; SLEEP QUALITY; SLEEP THERAPY; SLEEP TIME; SLEEP WAKING CYCLE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ATTITUDE TO HEALTH; BLOOD PRESSURE; CLINICAL TRIAL; COMPUTER ASSISTED THERAPY; HEALTH BEHAVIOR; INTERNET; IRELAND; METHODOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; RISK FACTOR; RISK REDUCTION; SLEEP; SLEEP DISORDERS; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

BLOOD PRESSURE; CLINICAL PROTOCOLS; COGNITIVE THERAPY; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; INTENTION TO TREAT ANALYSIS; INTERNET; IRELAND; LINEAR MODELS; PATIENT EDUCATION AS TOPIC; RESEARCH DESIGN; RISK FACTORS; RISK REDUCTION BEHAVIOR; SLEEP; SLEEP DISORDERS; THERAPY, COMPUTER-ASSISTED; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929942467     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-393     Document Type: Article

References (34)

1. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D: Short sleep duration as a risk factor for hypertension: analyses of the first national health and nutrition examination survey. Hypertension 2006, 47:833-839. 10.1161/01.HYP.0000217362.34748.e0
2. Krueger PM, Friedman EM: Sleep duration in the United States: a cross-sectional population-based study. Am J Epidemiol 2009, 169:1052-1063. 10.1093/aje/kwp023.
3. Patel SR, Malhotra A, White DP, Gottlieb DJ, Hu FB: Association between reduced sleep and weight gain in women. Am J Epidemiol 2006, 164:947-954. 10.1093/aje/kwj280.
4. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB: Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 2005, 28:1289-1296.
5. Sabanayagam C, Shankar A: Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Sleep 2010, 33:1037-1042.
6. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA: Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 2011, 32:1484-1492. 10.1093/eurheartj/ehr007.
7. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA: Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010, 33:585-592.
8. Kotani K, Saiga K, Sakane N, Mu H, Kurozawa Y: Sleep status and blood pressure in a healthy normotensive female population. Int J Cardiol 2008, 125:425-427. 10.1016/j.ijcard.2007.01.047.
9. Cappuccio FP, Stranges S, Kandala NB, Miller MA, Taggart FM, Kumari M, Ferrie JE, Shipley MJ, Brunner EJ, Marmot MG: Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study. Hypertension 2007, 50:693-700. 10.1161/HYPERTENSIONAHA.107.095471.
10. Kawabe H, Saito I: Does short sleep duration in daily life affect morning home blood pressure? Evaluation in Japanese people. Clin Exp Hypertens 2008, 30:183-190. 10.1080/10641960802064575.
11. Javaheri S, Storfer-Isser A, Rosen CL, Redline S: Sleep quality and elevated blood pressure in adolescents. Circulation 2008, 118:1034-1040. 10.1161/CIRCULATIONAHA.108.766410.
12. Knutson KL, Van Cauter E, Rathouz PJ, Yan LL, Hulley SB, Liu K, Lauderdale DS: Association between sleep and blood pressure in midlife: The CARDIA Sleep Study. Arch Intern Med 2009, 169:1055-1061. 10.1001/archinternmed.2009.119.
13. Knutson KL: Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best Pract Res Clin Endocrinol Metab 2010, 24:731-743. 10.1016/j.beem.2010.07.001.
14. Spiegel K, Leproult R, Van Cauter E: Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439. 10.1016/S0140-6736(99)01376-8.
15. Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R: Effects of insufficient sleep on blood pressure in hypertensive participants: a 24-h study. Am J Hypertens 1999, 12:63-68.
16. Lusardi P, Mugellini A, Preti P, Zoppi A, Derosa G, Fogari R: Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects. Am J Hypertens 1996, 9:503-505. 10.1016/0895-7061(95)00389-4.
17. Tochikubo O, Ikeda A, Miyajima E, Ishii M: Effects of insufficient sleep on blood pressure monitored by a New multibiomedical recorder. Hypertension 1996, 27:1318-1324. 10.1161/01.HYP.27.6.1318.
18. Nagai M, Hoshide S, Kario K: Sleep duration as a risk factor for cardiovascular disease: a review of the recent literature. Curr Cardiol Rev 2010, 6:54-61. 10.2174/157340310790231635.
19. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E: Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 2005, 99:2008-2019. 10.1152/japplphysiol.00660.2005.
20. Spiegel K, Tasali E, Penev P, Cauter EV: Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141:846-850. 10.7326/0003-4819-141-11-200412070-00008.
21. Flier JS, Elmquist JK: A good night's sleep: future antidote to the obesity epidemic? Ann Intern Med 2004, 141:885-886. 10.7326/0003-4819-141-11-200412070-00014.
22. McGrath ER, Glynn LG, Murphy AW, Conghaile AO, Canavan M, Reid C, Moloney B, O'Donnell MJ: Preventing cardiovascular disease in primary care: role of a national risk factor management program. Am Heart J 2012, 163:714-719. 10.1016/j.ahj.2012.01.027.
23. Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE, Kvale G, Nielsen GH, Nordhus IH: Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006, 295:2851-2858. 10.1001/jama.295.24.2851.
24. Espie CA, MacMahon KM, Kelly HL, Broomfield NM, Douglas NJ, Engleman HM, McKinstry B, Morin CM, Walker A, Wilson P: Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep 2007, 30:574-584.
25. Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, Brown JS: A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 2012, 35:769-781.
26. Morris A, Coverson D, Fike L, Ahmed Y, Stoyanova N, Hooper WC, Gibbons G, Bliwise D, Vaccarino V, Din-Dzietham R, Quyyumi A: Abstract 17806: Sleep quality and duration are associated with higher levels of inflammatory biomarkers: the META-Health Study. Circulation 2010,122(21_MeetingAbstracts):A17806.
27. Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, Douglas NJ, Engleman HM, Kelly HL, Paul J: Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in participants with cancer. J Clin Oncol 2008, 26:4651-4658. 10.1200/JCO.2007.13.9006.
28. Boggia J, Thijs L, Hansen TW, Li Y, Kikuya M, Bjrklund-Bodegrd K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Olszanecka A, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Maestre G, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA: Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension 2011, 57:397-405. 10.1161/HYPERTENSIONAHA.110.156828.
29. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952. 10.1016/S0140-6736(04)17018-9.
30. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S: Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123. 10.1016/S0140-6736(10)60834-3.
31. Miller ER 3rd, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, Wasan SK, Appel LJ: Results of the diet, exercise, and weight loss intervention trial (DEW-IT). Hypertension 2002, 40:612-618. 10.1161/01.HYP.0000037217.96002.8E.
32. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med 1997, 336:1117-1124. 10.1056/NEJM199704173361601.
33. Martin JE, Dubbert PM, Cushman WC: Controlled trial of aerobic exercise in hypertension. Circulation 1990, 81:1560-1567. 10.1161/01.CIR.81.5.1560.
34. Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B: Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in participants with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007, 370:829-840. 10.1016/S0140-6736(07)61303-8.